{"disease":{"id":"thrombotic-infarction","name":"thrombotic infarction"},"drugs":{"marketed":[{"drug_id":"oral-p2y12-receptor-blocker","indication_name":"Prevention of atherothrombotic events in patients with acute coronary syndrome (ACS) or a history of myocardial infarction (MI)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Oral P2Y12 receptor blocker","company_name":"Italian Society of Invasive Cardiology","drug_phase":"marketed","molecular_target":"P2Y12 adenosine diphosphate receptor on platelet surface","drug_class":"Antiplatelet agent; P2Y12 receptor antagonist; Thienopyridine or non-thienopyridine class","quality_score":22,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04749992","title":"Biological Function of Dreaming in Dreaming and Non-Dreaming Patients With PCA Infarction","phase":"","overall_status":"TERMINATED","enrollment_count":142,"lead_sponsor_name":"International Psychoanalytic University Berlin","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}